Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Cash from Operations (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Cash from Operations for 6 consecutive years, with 18441000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 23.05% year-over-year to 18441000.0, compared with a TTM value of 51916000.0 through Dec 2025, up 32.81%, and an annual FY2025 reading of 51916000.0, up 32.81% over the prior year.
  • Cash from Operations was 18441000.0 for Q4 2025 at Viemed Healthcare, roughly flat from 18367000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 18441000.0 in Q4 2025 and bottomed at 1175000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 9322950.0, with a median of 8313500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations skyrocketed 662.44% in 2021, then crashed 88.81% in 2024.
  • Year by year, Cash from Operations stood at 8655000.0 in 2021, then decreased by 11.22% to 7684000.0 in 2022, then surged by 72.88% to 13284000.0 in 2023, then increased by 12.82% to 14987000.0 in 2024, then rose by 23.05% to 18441000.0 in 2025.
  • Business Quant data shows Cash from Operations for VMD at 18441000.0 in Q4 2025, 18367000.0 in Q3 2025, and 12254000.0 in Q2 2025.